Top Markets
Coin of the day
Aceragen, Inc. Aceragen, Inc.

Aceragen, Inc.

ACGN
Classement en actions #39037
Aceragen, Inc., a biopharmaceutical firm in its clinical development phase,... Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.
Prix de l'action
$0.38
Dernière synchronisation: 2023-09-01
Capitalisation boursière
$677.16K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Aceragen, Inc. (ACGN)

Catégorie

Le prix ACGN avec la capitalisation boursière de B
Aceragen, Inc. Aceragen, Inc.
ACGN
$0.38
Capitalisation boursière de Aceragen, Inc.(ACGN)
Capitalisation boursière: $677.16K
En August 2026, Aceragen, Inc. a une capitalisation boursière de $677.16K. Cela fait de Aceragen, Inc. la 39037th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Aceragen, Inc. du 1996 au 2026
ACGN par rapport au top 5 des plus populaires stocks
Prix pour ACGN L’actif B La capitalisation boursière de B Résultats
Aceragen, Inc. Aceragen, Inc.
$3,069,325 $677.16K
$5.470T +807,717,098.00%
Aceragen, Inc. Aceragen, Inc.
$2,506,774 $677.16K
$4.467T +659,677,258.86%
Aceragen, Inc. Aceragen, Inc.
$2,342,529 $677.16K
$4.174T +616,454,853.99%
Aceragen, Inc. Aceragen, Inc.
$2,076,362 $677.16K
$3.700T +546,410,985.93%
Aceragen, Inc. Aceragen, Inc.
$1,601,764 $677.16K
$2.854T +421,516,631.57%